Skip to content
DD

DuPont de Nemours, Inc.

DuPont de Nemours, Inc. Q3 FY2024 earnings call

November 5, 2024 · fiscal period ended 2024-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-11-05

Management highlights

Management Statement and Operational Highlights

  • Strong Financial Performance: Third quarter net sales $3.2 billion, organic sales growth 3%, operating EBITDA $857 million up 11%, adjusted EPS $1.18 up 28%.
  • Volume Recovery: Continued broad-based growth in electronics end markets, return to year-over-year volume growth in Water Solutions.
  • Operational Excellence: Progress on operational excellence initiatives, 30,000 hours of training year-to-date, benefits from restructuring actions.
  • Acquisitions: Completed acquisition of Donatelle, integrating it into Spectrum and seeing cross-selling opportunities.
  • Separations Progress: Making progress on separations of electronics and water businesses, expect to announce boards and key executives by first quarter 2025.
View in transcript ↓

Segment performance

Segment Performance

  • Electronics and Industrial (E&I): Organic sales grew 10%, with sales of $1.6 billion. Operating EBITDA was $467 million, up 22% year-over-year. Organic sales growth driven by double-digit volume growth in semi and Interconnect Solutions, and integration of Donatelle. Operating EBITDA margin was 30.1%, up 210 basis points.
  • Water & Protection (W&P): Net sales of $1.4 billion declined 2% year-over-year. Organic sales decline moderated to 2%, with Water Solutions seeing return to year-over-year sales growth. Operating EBITDA was $364 million, up 1% year-over-year. Seasonality and pricing headwinds affected the segment, but medical packaging saw sequential sales growth.
View in transcript ↓

Guidance

Guidance

  • Full Year 2024: Raising guidance for operating EBITDA and adjusted EPS. Full year 2024 now expects operating EBITDA ~$3.125 billion and adjusted EPS ~$3.90 per share.
  • Fourth Quarter: Expect net sales ~$3.07 billion, operating EBITDA ~$790 million, adjusted EPS ~$0.98 per share. Sees normal seasonal declines in electronics and construction markets but recovery in water and medical packaging.
View in transcript ↓

Risks

Risks

  • Forward-Looking Statements: Actual performance may differ from forward-looking statements due to risks and uncertainties.
  • Separation Risks: Uncertainties related to the timing and execution of the separations of electronics and water businesses.
  • Market Conditions: Risks from macroeconomic conditions, including currency headwinds, demand fluctuations in certain end markets (e.g., China solar markets).
View in transcript ↓

Q&A highlights

Question and Answer

Q: What are the gating factors for the separations timeline?

A: Legal entity work and IT separation work are key, teams have made progress, confidence in moving towards 18-month timeline.

Q: Why did customers prebuy in electronics?

A: Tied to new fabs in China coming online, prebuying to get through qualifications and ramp.

Q: Trends in exiting September and October?

A: Normal seasonality, water space strongest last month, no major variability outside seasonality.

Q: Kalrez destocking?

A: At bottom, expected to stabilize and recover in 2025, tied to semi-CapEx exposure.

Q: Interest rates impact?

A: Front end rate cuts benefit North America residential construction; broader rate cuts benefit all businesses.

Q: Alternatives to spins for Water or Electronic businesses?

A: Plan is to proceed with separations, moving rapidly towards announcing boards and executives for new companies by first quarter 2025.

Q: Price givebacks in Shelter?

A: Expect price givebacks carryforward into 2025, dependent on cost analysis vs. raws, logistics, utilities.

Q: Competitive dynamics in China electronics?

A: DuPont has outsized exposure in China semi space, favorable position with local and global OEMs in China.

Q: Free cash flow and deployment?

A: Strong free cash flow conversion, majority of cash in 2025 used for separation costs, no significant share repurchases or outsized CapEx expected next year.

Q: ITC complaint on Tyvek?

A: Defending patents and trade secrets, Tyvek business recovering, especially in medical packaging.

Q: New products in development?

A: Battery adhesives win with large European OEM, growth in healthcare via Donatelle acquisition and cross-selling opportunities.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 5, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.